Abstract: The invention provides compositions including anti-tryptase antibodies and pharmaceutical compositions thereof, as well as methods of using the same.

Abstract: The present invention is directed to anti-PVRIG antibodies and stable liquid pharmaceutical formulations thereof. The present invention is directed to monotherapy and combination treatments with anti-PVRIG antibodies and anti-PD-1 antibodies, in particular nivolumab, using stable liquid pharmaceutical formulations thereof.

Abstract: Systems and methods for provisioning and managing a network are disclosed. One method can comprise determining location information of one or more access points and selecting a routing device based upon the location information. Communication can be established between the one or more access points and the select routing device to define a mobility group comprising the one or more access points.

Abstract: Systems and methods for provisioning and managing a network are disclosed. One method can comprise determining location information of one or more access points and selecting a routing device based upon the location information. Communication can be established between the one or more access points and the select routing device to define a mobility group comprising the one or more access points.

Abstract: Systems and methods for provisioning and managing a network are disclosed. One method can comprise determining location information of one or more access points and selecting a routing device based upon the location information. Communication can be established between the one or more access points and the select routing device to define a mobility group comprising the one or more access points.

Abstract: Systems and methods for provisioning and managing a network are disclosed. One method can comprise determining location information of one or more access points and selecting a routing device based upon the location information. Communication can be established between the one or more access points and the select routing device to define a mobility group comprising the one or more access points.

Abstract: Glass substrates and methods for forming glass substrates are disclosed. The glass substrates include a planar A-side surface having a surface roughness Ra1 of less than 0.5 nm and a planar B-side having a surface roughness Ra2 wherein the ratio Ra2:Ra1 is greater than or equal to about 1.5. A plurality of texturing features are formed in the B-side surface. The plurality of texturing features have a peak-to-valley height H such that 0.05 ?m?H?3.75 ?m. The texturing features are distributed in the B-side surface such that a center-to-center pitch P between adjacent texturing features is at least 1.5 mm in at least one direction. The plurality of texturing features are formed in the B-side surface while the glass substrate is at a temperature T1, wherein 600° C.?T1?1200° C. and a viscosity of the glass substrate is from greater than 150,000 Poise and less than 1013 Poise.

Abstract: A process and apparatus for cutting a continuous glass ribbon involving the use of edge restrainers such as suction cups and clamps connected to an actuator of a robot tooling through a flexible linkage capable of reciprocal motion in the direction of the ribbon velocity. The use of the flexible linkage reduces peak pulling-force when the glass ribbon is pulled or pushed laterally to during bending and separation along a pre-formed score-line. The invention can be advantageously used in the bottom of the draw of a vertical down-draw forming process.

Abstract: A three dimensional audio playback system in which the audio clips are determined by location. The audio playback system being located within a vehicle to aid in navigation or for entertainment or informational or safety purposes.

Abstract: Systems and methods for provisioning and managing a network are disclosed. One method can comprise determining location information of one or more access points and selecting a routing device based upon the location information. Communication can be established between the one or more access points and the select routing device to define a mobility group comprising the one or more access points.

Abstract: Visual analysis of urine samples is carried out with the use of a slide consisting of three layers containing an enclosed viewing chamber which receives a urine sample deposited by pipette into an opening on the outer layer of the slide. From the inlet opening the sample enters an inlet chamber in the middle layer and passes through a capillary passageway into the viewing chamber where it is inspected for particles and sediments.

Abstract: A three dimensional audio playback system in which the audio clips are determined by location. The audio playback system being located within a vehicle to aid in navigation or for entertainment or informational or safety purposes.

Abstract: Glass substrates and methods for forming glass substrates are disclosed. The glass substrates include a planar A-side surface having a surface roughness Ra1 of less than 0.5 nm and a planar B-side having a surface roughness Ra2 wherein the ratio Ra2:Ra1 is greater than or equal to about 1.5. A plurality of texturing features are formed in the B-side surface. The plurality of texturing features have a peak-to-valley height H such that 0.05 ?m?H?3.75 ?m. The texturing features are distributed in the B-side surface such that a center-to-center pitch P between adjacent texturing features is at least 1.5 mm in at least one direction. The plurality of texturing features are formed in the B-side surface while the glass substrate is at a temperature T1, wherein 600° C.?T1?1200 ° C. and a viscosity of the glass substrate is from greater than 150,000 Poise and less than 1013 Poise.

Abstract: A sample collection device having a sample container and microfluidic device having one or more microfluidic circuits, the system for analyzing biological samples. The microfluidic device has a sample inlet port, a microconduit in communication with the inlet port and with reaction chamber. The reaction chamber is connected to an air vent via another microconduit. Air may be vented from the microfluidic circuit via the air vent of the microfluidic circuit via an air vent in the sample container.

Abstract: A process and apparatus for cutting a continuous glass ribbon involving the use of edge restrainers such as suction cups and clamps connected to an actuator of a robot tooling through a flexible linkage capable of reciprocal motion in the direction of the ribbon velocity. The use of the flexible linkage reduces peak pulling-force when the glass ribbon is pulled or pushed laterally to during bending and separation along a pre-formed score-line. The invention can be advantageously used in the bottom of the draw of a vertical down-draw forming process.

Abstract: Visual analysis of urine samples is carried out with the use of a slide consisting of three layers containing an enclosed viewing chamber which receives a urine sample deposited by pipette into an opening on the outer layer of the slide. From the inlet opening the sample enters an inlet chamber in the middle layer and passes through a capillary passageway into the viewing chamber where it is inspected for particles and sediments.

Abstract: The present invention relates to benzisothiazoles and pharmaceutical compositions thereof that inhibit replication and/or proliferation of HCV virus. The present invention also relates to the use of the benzisothiazoles and pharmaceutical compositions comprising the compounds to treat or prevent HCV infections.

Abstract: The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.

Abstract: The present invention relates to substituted diphenyl heterocycle compounds having an oxadiazole moiety and pharmaceutical compositions thereof that inhibit replication of HCV virus. The present invention also relates to the use of the compounds and/or compositions to inhibit HCV replication and/or proliferation and to treat or prevent HCV infections.

Abstract: The present invention relates to prodrugs and compositions thereof useful for treating or preventing Hepatitis C virus (HCV) infections. In particular, the present invention relates to prodrugs of substituted diphenyl-, diheteroaryl- and mixed phenyl heteroaryl substituted five-membered heterocycle compounds, compositions comprising the compounds and the use of such compounds and compositions to inhibit HCV replication and/or proliferation as a therapeutic approach towards the treatment and/or prevention of HCV infections in humans and animals.